Michelle N. Rheault

Michelle N. Rheault

Transplant Surgery | Pediatric Nephrology

9680 Tamarack Road
Suite 130
Woodbury, MN 55125

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 22, 2026

Primary Glomerular Diseases in the Elderly: Clinical Features, Treatment Patterns, and Outcomes in the CureGN Cohort.

Primary Glomerular Diseases in the Elderly: Clinical Features, Treatment Patterns, and Outcomes in the CureGN Cohort.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 26, 2026

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 09, 2026

Sparsentan Versus Irbesartan in Pediatric Patients With FSGS.

Sparsentan Versus Irbesartan in Pediatric Patients With FSGS.

Journal: Kidney international reports

Published: February 04, 2026

Urine Screening for Early Diagnosis of Young Individuals With Alport Syndrome: A Call for Action.

Urine Screening for Early Diagnosis of Young Individuals With Alport Syndrome: A Call for Action.

Journal: Kidney international reports

Published: December 22, 2025

Tiny Kidneys, Big Impact: The Corticosteroid Dilemma in Premature Neonates.

Tiny Kidneys, Big Impact: The Corticosteroid Dilemma in Premature Neonates.

Journal: Kidney360

Published: September 25, 2025

Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome.

Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome.

Journal: medRxiv : the preprint server for health sciences

Published: September 19, 2025

Treatment Approaches for Alport Syndrome.

Treatment Approaches for Alport Syndrome.

Journal: Journal of the American Society of Nephrology : JASN

Published: September 12, 2025

Polygenic risk scores and HLA class II variants are biomarkers of corticosteroid response in childhood nephrotic syndrome.

Polygenic risk scores and HLA class II variants are biomarkers of corticosteroid response in childhood nephrotic syndrome.

Journal: Kidney international

Published: August 06, 2025

Transcontinental Practice Patterns in Pediatric Recurrent Focal Segmental Glomerulosclerosis: Barriers to Consensus and Adequately Powered Studies.

Transcontinental Practice Patterns in Pediatric Recurrent Focal Segmental Glomerulosclerosis: Barriers to Consensus and Adequately Powered Studies.

Journal: Pediatric transplantation

Published: August 05, 2025

Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial.

Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: June 26, 2025

Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network.

Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network.

Journal: Kidney medicine

Published: June 13, 2025

Showing 1-12 of 106

Last Updated: 09/26/2026